The Flowflex Influenza A/B Test Kit is a qualitative, lateral flow immunoassay designed for the simultaneous and differential detection of nucleocapsid protein antigens from Influenza Type A (including H1N1, H3N2) and Influenza Type B. This rapid diagnostic test (RDT) provides clinical-grade results in a decentralized setting, facilitating early antiviral intervention.

• Dual-Path Detection: Utilizes distinct monoclonal antibodies to differentiate between Flu A and Flu B strains on a single test strip.
• Rapid Analytical Time: Delivers definitive results within 15 minutes, significantly reducing the time to diagnosis compared to laboratory-based RT-PCR.
• High Diagnostic Sensitivity: Engineered for high affinity toward viral nucleoproteins, ensuring reliable detection even during early stages of viral shedding.
• Minimally Invasive Sampling: Optimized for use with nasal swabs, providing a more comfortable patient experience compared to deep nasopharyngeal sampling.
• Self-Contained System: Each kit includes a pre-filled extraction buffer tube, a sterile swab, and a test cassette, minimizing the risk of procedural cross-contamination.

Recommended Usage: For symptomatic individuals, use within the first 3–4 days of symptom onset when viral load is highest. Follow the "swab, swirl, and squeeze" protocol exactly as outlined in the instructions. Note: A negative result does not definitively rule out influenza infection; if symptoms persist or worsen, clinical consultation and molecular testing (PCR) are recommended.